大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/10/21 | 1,682 | 1,691 | 1,651 | 1,675 | -7 | -0.4% | 94,000 |
| 2013/10/18 | 1,698 | 1,698 | 1,664 | 1,682 | -7 | -0.4% | 99,700 |
| 2013/10/17 | 1,680 | 1,709 | 1,661 | 1,689 | +2 | +0.1% | 176,100 |
| 2013/10/16 | 1,671 | 1,689 | 1,666 | 1,687 | +24 | +1.4% | 190,600 |
| 2013/10/15 | 1,675 | 1,679 | 1,638 | 1,663 | -5 | -0.3% | 96,000 |
| 2013/10/11 | 1,682 | 1,688 | 1,635 | 1,668 | +3 | +0.2% | 137,700 |
| 2013/10/10 | 1,660 | 1,699 | 1,646 | 1,665 | +66 | +4.1% | 384,600 |
| 2013/10/09 | 1,550 | 1,600 | 1,540 | 1,599 | +33 | +2.1% | 61,400 |
| 2013/10/08 | 1,555 | 1,577 | 1,545 | 1,566 | -5 | -0.3% | 53,700 |
| 2013/10/07 | 1,617 | 1,617 | 1,570 | 1,571 | -40 | -2.5% | 62,600 |
| 2013/10/04 | 1,624 | 1,625 | 1,601 | 1,611 | -7 | -0.4% | 64,900 |
| 2013/10/03 | 1,586 | 1,634 | 1,585 | 1,618 | +13 | +0.8% | 79,100 |
| 2013/10/02 | 1,650 | 1,650 | 1,590 | 1,605 | -33 | -2% | 99,000 |
| 2013/10/01 | 1,658 | 1,670 | 1,633 | 1,638 | -14 | -0.8% | 128,500 |
| 2013/09/30 | 1,623 | 1,672 | 1,594 | 1,652 | +29 | +1.8% | 183,700 |
| 2013/09/27 | 1,590 | 1,625 | 1,587 | 1,623 | +36 | +2.3% | 113,600 |
| 2013/09/26 | 1,555 | 1,590 | 1,550 | 1,587 | +20 | +1.3% | 60,000 |
| 2013/09/25 | 1,604 | 1,604 | 1,560 | 1,567 | -24 | -1.5% | 62,400 |
| 2013/09/24 | 1,600 | 1,607 | 1,575 | 1,591 | ±0 | ±0% | 62,900 |
| 2013/09/20 | 1,578 | 1,597 | 1,560 | 1,591 | +13 | +0.8% | 88,900 |
| 2013/09/19 | 1,590 | 1,615 | 1,571 | 1,578 | +7 | +0.4% | 95,800 |
| 2013/09/18 | 1,580 | 1,587 | 1,570 | 1,571 | -9 | -0.6% | 50,500 |
| 2013/09/17 | 1,590 | 1,607 | 1,562 | 1,580 | -9 | -0.6% | 68,300 |
| 2013/09/13 | 1,545 | 1,594 | 1,545 | 1,589 | +34 | +2.2% | 73,200 |
| 2013/09/12 | 1,557 | 1,575 | 1,544 | 1,555 | -3 | -0.2% | 28,000 |
| 2013/09/11 | 1,527 | 1,585 | 1,526 | 1,558 | +25 | +1.6% | 71,400 |
| 2013/09/10 | 1,565 | 1,565 | 1,529 | 1,533 | -34 | -2.2% | 118,600 |
| 2013/09/09 | 1,567 | 1,577 | 1,550 | 1,567 | -8 | -0.5% | 75,900 |
| 2013/09/06 | 1,592 | 1,599 | 1,568 | 1,575 | -26 | -1.6% | 64,100 |
| 2013/09/05 | 1,622 | 1,625 | 1,589 | 1,601 | -14 | -0.9% | 61,700 |
| 2013/09/04 | 1,600 | 1,621 | 1,589 | 1,615 | +15 | +0.9% | 78,200 |
| 2013/09/03 | 1,599 | 1,609 | 1,582 | 1,600 | +27 | +1.7% | 84,600 |
| 2013/09/02 | 1,567 | 1,606 | 1,567 | 1,573 | +6 | +0.4% | 73,500 |
| 2013/08/30 | 1,572 | 1,606 | 1,567 | 1,567 | -13 | -0.8% | 88,500 |
| 2013/08/29 | 1,575 | 1,605 | 1,574 | 1,580 | -9 | -0.6% | 42,100 |
| 2013/08/28 | 1,581 | 1,610 | 1,577 | 1,589 | -14 | -0.9% | 104,000 |
| 2013/08/27 | 1,560 | 1,640 | 1,560 | 1,603 | +35 | +2.2% | 167,800 |
| 2013/08/26 | 1,576 | 1,614 | 1,565 | 1,568 | -35 | -2.2% | 112,700 |
| 2013/08/23 | 1,619 | 1,665 | 1,583 | 1,603 | -5 | -0.3% | 270,300 |
| 2013/08/22 | 1,605 | 1,642 | 1,582 | 1,608 | +3 | +0.2% | 287,100 |
| 2013/08/21 | 1,610 | 1,615 | 1,561 | 1,605 | -15 | -0.9% | 297,500 |
| 2013/08/20 | 1,588 | 1,650 | 1,581 | 1,620 | +55 | +3.5% | 953,400 |
| 2013/08/19 | 1,464 | 1,568 | 1,458 | 1,565 | +131 | +9.1% | 436,500 |
| 2013/08/16 | 1,465 | 1,478 | 1,430 | 1,434 | -30 | -2% | 91,300 |
| 2013/08/15 | 1,436 | 1,540 | 1,423 | 1,464 | +23 | +1.6% | 271,700 |
| 2013/08/14 | 1,403 | 1,448 | 1,403 | 1,441 | +9 | +0.6% | 136,400 |
| 2013/08/13 | 1,450 | 1,454 | 1,371 | 1,432 | +132 | +10.2% | 360,900 |
| 2013/08/12 | 1,325 | 1,325 | 1,295 | 1,300 | +5 | +0.4% | 43,900 |
| 2013/08/09 | 1,300 | 1,324 | 1,295 | 1,295 | +4 | +0.3% | 22,600 |
| 2013/08/08 | 1,285 | 1,329 | 1,285 | 1,291 | +9 | +0.7% | 35,900 |
2851～
2900
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
